Published in J Allergy Clin Immunol on January 01, 2005
Specific oral desensitization in children with IgE-mediated cow's milk allergy. Evolution in one year. Eur J Pediatr (2012) 2.08
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. World Allergy Organ J (2010) 2.01
Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol (2012) 1.70
Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1. Nat Med (2010) 1.28
Food allergy. J Clin Invest (2011) 1.27
Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol (2011) 1.11
Allergic sensitization can be induced via multiple physiologic routes in an adjuvant-dependent manner. J Allergy Clin Immunol (2011) 0.98
Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin. J Allergy Clin Immunol (2011) 0.98
Immunology in the Clinic Review Series; focus on allergies: immunotherapy for food allergy. Clin Exp Immunol (2012) 0.98
Pathophysiology of food allergy. Pediatr Clin North Am (2011) 0.95
Dietary supplementation with omega-3-PUFA-rich fish oil reduces signs of food allergy in ovalbumin-sensitized mice. Clin Dev Immunol (2011) 0.95
T-lymphocyte responses to intestinally absorbed antigens can contribute to adipose tissue inflammation and glucose intolerance during high fat feeding. PLoS One (2010) 0.93
Food allergies: the basics. Gastroenterology (2015) 0.90
Molecular and cellular mechanisms of food allergy and food tolerance. J Allergy Clin Immunol (2016) 0.90
Food allergy: recent advances in pathophysiology and treatment. Allergy Asthma Immunol Res (2009) 0.90
Probiotic preparation VSL#3 alters the distribution and phenotypes of dendritic cells within the intestinal mucosa in C57BL/10J mice. J Nutr (2009) 0.87
The importance of TSLP in allergic disease and its role as a potential therapeutic target. Expert Rev Clin Immunol (2014) 0.86
The future of food allergy therapeutics. Semin Immunopathol (2012) 0.84
The immunology of food allergy. J Immunol (2014) 0.83
Mucosal immunology of tolerance and allergy in the gastrointestinal tract. Immunol Res (2012) 0.83
Importance of gastrointestinal ingestion and macromolecular antigens in the vein for oral tolerance induction. Immunology (2006) 0.82
Evaluation of dairy allergy among ulcerative colitis patients. Bioinformation (2014) 0.81
Oral desensitization for food hypersensitivity. Immunol Allergy Clin North Am (2011) 0.81
Antibiotic administration early in life impairs specific humoral responses to an oral antigen and increases intestinal mast cell numbers and mediator concentrations. Clin Vaccine Immunol (2006) 0.81
FOXP3, IL-10, and TGF-β genes expression in children with IgE-dependent food allergy. J Clin Immunol (2010) 0.81
Indication of immune activation in patients with perceived food hypersensitivity. Dig Dis Sci (2013) 0.80
Expression of integrin alphavbeta6 in the intestinal epithelial cells of patients with inflammatory bowel disease. N Am J Med Sci (2009) 0.80
Alcohol-induced gastritis prevents oral tolerance induction in mice. Clin Exp Immunol (2006) 0.80
Early oral ovalbumin exposure during maternal milk feeding prevents spontaneous allergic sensitization in allergy-prone rat pups. Clin Dev Immunol (2011) 0.79
Gut T cell receptor-γδ(+) intraepithelial lymphocytes are activated selectively by cholera toxin to break oral tolerance in mice. Clin Exp Immunol (2015) 0.79
Food allergy in gastroenterologic diseases: Review of literature. World J Gastroenterol (2006) 0.79
Oral and sublingual immunotherapy for food allergy. World Allergy Organ J (2014) 0.79
Properties of Gluten Intolerance: Gluten Structure, Evolution, Pathogenicity and Detoxification Capabilities. Nutrients (2016) 0.79
Prolonged ingestion of ovalbumin diet by sensitized mice improves the metabolic consequences induced by experimental food allergy. Clin Exp Immunol (2014) 0.78
Pathogenesis of food allergy in the pediatric patient. Curr Allergy Asthma Rep (2012) 0.78
Ciclesonide for the treatment of asthma. Ther Clin Risk Manag (2006) 0.78
Transforming growth factor beta (TGFβ1) in breast milk and indicators of infant atopy in a birth cohort. Pediatr Allergy Immunol (2014) 0.77
Wheat allergy: diagnosis and management. J Asthma Allergy (2016) 0.77
Dendritic cell populations in patients with self-reported food hypersensitivity. Int J Gen Med (2011) 0.77
LPS promotes Th2 dependent sensitisation leading to anaphylaxis in a Pru p 3 mouse model. Sci Rep (2017) 0.76
Potential non-T cells source of interleukin-4 in food allergy. Pediatr Allergy Immunol (2014) 0.76
Elements Involved In Promoting Eosinophilic Gastrointestinal Disorders. J Genet Syndr Gene Ther (2015) 0.76
Participation of Leukotrienes in the Immune Modulation of Oral Tolerance. Front Microbiol (2017) 0.75
Role of Regulatory Cells in Oral Tolerance. Allergy Asthma Immunol Res (2017) 0.75
The Role of Skin Barrier in the Pathogenesis of Food Allergy. Children (Basel) (2015) 0.75
Future therapies for food allergy. Hum Vaccin Immunother (2012) 0.75
Hapten may play an important role in food allergen-related intestinal immune inflammation. N Am J Med Sci (2011) 0.75
Food Allergy and Intolerance in IBS. Gastroenterol Hepatol (N Y) (2006) 0.75
Induction of Oral Tolerance by Gamma-Irradiated Ovalbumin Administration. Korean J Food Sci Anim Resour (2016) 0.75
Regulatory T Cell Induced by Poria cocos Bark Exert Therapeutic Effects in Murine Models of Atopic Dermatitis and Food Allergy. Mediators Inflamm (2016) 0.75
The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow's milk- and peanut allergy models. Clin Transl Allergy (2017) 0.75
Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med (2004) 7.93
Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science (2013) 3.74
Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med (2011) 3.06
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. Clin Gastroenterol Hepatol (2004) 2.99
Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res (2005) 2.91
Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis (2012) 2.23
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol (2008) 2.16
The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol (2003) 2.06
Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol (2008) 2.05
The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells. Gastroenterology (2004) 2.02
Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract. J Exp Med (2013) 1.99
The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol (2012) 1.96
Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology (2010) 1.92
Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology (2008) 1.89
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology (2003) 1.70
The immune response in inflammatory bowel disease. Am J Gastroenterol (2007) 1.67
A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology (2007) 1.64
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology (2007) 1.60
Monoclonal antibodies, immunogenicity, and associated infusion reactions. Mt Sinai J Med (2005) 1.57
Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res (2007) 1.53
Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells. Blood (2012) 1.53
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis. Gut (2010) 1.53
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. J Biol Chem (2006) 1.52
Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis (2006) 1.51
The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice. J Clin Invest (2010) 1.50
Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology (2002) 1.49
CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology (2007) 1.47
Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol (2005) 1.43
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol (2009) 1.39
Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology (2004) 1.33
Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism. J Immunol (2009) 1.33
Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol (2009) 1.30
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis (2010) 1.28
Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol (2008) 1.26
Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J Clin Invest (2005) 1.25
Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy. J Allergy Clin Immunol (2010) 1.25
Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol (2013) 1.24
Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun (2011) 1.23
Epithelial: lamina propria lymphocyte interactions promote epithelial cell differentiation. Gastroenterology (2007) 1.23
Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm Bowel Dis (2007) 1.21
Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis (2011) 1.21
Regulatory T cells: peace keepers in the gut. Inflamm Bowel Dis (2004) 1.17
CD4 T cells activated in the mesenteric lymph node mediate gastrointestinal food allergy in mice. Am J Physiol Gastrointest Liver Physiol (2007) 1.17
AP-1 activated by toll-like receptors regulates expression of IL-23 p19. J Biol Chem (2009) 1.17
Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet (2004) 1.17
Epithelia: lymphocyte interactions in the gut. Immunol Rev (2007) 1.15
Thymic stromal lymphopoietin is required for gastrointestinal allergy but not oral tolerance. Gastroenterology (2010) 1.12
MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. J Biol Chem (2009) 1.12
Ubiquitin-dependent degradation of interferon regulatory factor-8 mediated by Cbl down-regulates interleukin-12 expression. J Biol Chem (2005) 1.11
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study. BMC Med Genet (2011) 1.10
Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol (2013) 1.09
Activation of CD8+ regulatory T cells by human placental trophoblasts. J Immunol (2005) 1.09
Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am J Physiol Gastrointest Liver Physiol (2007) 1.08
Gastrointestinal manifestations in primary immune disorders. Inflamm Bowel Dis (2010) 1.08
The kinetics and pattern of tracheal allograft re-epithelialization. Am J Respir Cell Mol Biol (2003) 1.07
Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression. J Biol Chem (2002) 1.05
High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin Immunol (2010) 1.01
Notch-1 signaling regulates intestinal epithelial barrier function, through interaction with CD4+ T cells, in mice and humans. Gastroenterology (2010) 1.00
Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines. Inflamm Bowel Dis (2011) 0.99
Allergic sensitization can be induced via multiple physiologic routes in an adjuvant-dependent manner. J Allergy Clin Immunol (2011) 0.98
Orthotopic tracheal transplantation in the murine model. Transplantation (2002) 0.98
Activation of a unique population of CD8(+) T cells by intestinal epithelial cells. Ann N Y Acad Sci (2004) 0.95
Metabolic alterations to the mucosal microbiota in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.93
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis (2010) 0.92
A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans. Gastroenterology (2012) 0.92
Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis. Rapid Commun Mass Spectrom (2007) 0.91
Orthotopic tracheal allografts undergo reepithelialization with recipient-derived epithelium. Arch Otolaryngol Head Neck Surg (2003) 0.90
A functional role for CCR6 on proallergic T cells in the gastrointestinal tract. Gastroenterology (2009) 0.89
Mucosal epithelium in health and disease. Curr Mol Med (2005) 0.88
Evidence for a genetic defect in oral tolerance induction in inflammatory bowel disease. Inflamm Bowel Dis (2006) 0.88
Expression of the chemokine binding protein M3 promotes marked changes in the accumulation of specific leukocytes subsets within the intestine. Gastroenterology (2009) 0.87
Defect in CEACAM family member expression in Crohn's disease IECs is regulated by the transcription factor SOX9. Inflamm Bowel Dis (2009) 0.87
Oral tolerance and inflammatory bowel disease. Curr Opin Gastroenterol (2005) 0.87
Non-classical MHC class I molecules on intestinal epithelial cells: mediators of mucosal crosstalk. Immunol Rev (2005) 0.87
Allergen-IgE complexes trigger CD23-dependent CCL20 release from human intestinal epithelial cells. Gastroenterology (2007) 0.86
Can we produce true tolerance in patients with food allergy? J Allergy Clin Immunol (2013) 0.86
Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease. Expert Rev Clin Immunol (2010) 0.85
New proteomic approaches for biomarker discovery in inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.85
A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency. Gastroenterol Hepatol (N Y) (2007) 0.83
Mucosal immunology of tolerance and allergy in the gastrointestinal tract. Immunol Res (2012) 0.83
Enhanced oral tolerance in transgenic mice with hepatocyte secretion of IL-10. J Immunol (2005) 0.82
Immunopathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol (2002) 0.82
Failure to induce oral tolerance in Crohn's and ulcerative colitis patients: possible genetic risk. Ann N Y Acad Sci (2004) 0.81
Immunomodulatory roles of the carcinoembryonic antigen family of glycoproteins. Ann N Y Acad Sci (2006) 0.81
Meeting summary: Signal transduction pathways in immune and inflammatory cells. November 30-December 3, 2000, Amelia Island, Florida, U.S.A. Inflamm Bowel Dis (2003) 0.81
Transforming growth factor β signaling controls activities of human intestinal CD8(+)T suppressor cells. Gastroenterology (2012) 0.81
Use of GM-CSF in the treatment of colitis associated with chronic granulomatous disease. J Allergy Clin Immunol (2005) 0.81
The real meaning of translational research. Gastroenterology (2002) 0.80
Mitochondria influence Fas expression in gp120-induced apoptosis of neuronal cells. Int J Neurosci (2009) 0.80
Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update. Expert Rev Clin Immunol (2013) 0.79
Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study. Inflamm Bowel Dis (2009) 0.79
Anti-inflammatory effects of the Chinese herbal formula FAHF-2 in experimental and human IBD. Inflamm Bowel Dis (2014) 0.78
Lymphoepithelial interactions: a new paradigm. Ann N Y Acad Sci (2009) 0.78
Dead on arrival: understanding the failure of CTLA4-immunoglobulin therapy in inflammatory bowel disease. Gastroenterology (2012) 0.77
A novel approach to the treatment of ulcerative colitis: is it kosher? Gastroenterology (2005) 0.77
Working out mechanisms of controlled/physiologic inflammation in the GI tract. Immunol Res (2012) 0.77
Redefining autoimmunity. Gastroenterology (2003) 0.77
Potential non-T cells source of interleukin-4 in food allergy. Pediatr Allergy Immunol (2014) 0.76
Natural killer T cells in mucosal homeostasis. Ann N Y Acad Sci (2004) 0.76